Where We Live

Rethinking weight and health in the age of Ozempic

03.08.2024 - By Connecticut Public RadioPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

According to the National Institutes of Health, average body weight drastically increased across the board for men and women during the pandemic lockdown.

Simply eating less and exercising more hasn’t been that effective when it comes to weight loss. In efforts to fight weight stigma, doctors are embracing a new idea that weight loss isn’t all about willpower and health is defined by more than just someone’s weight.

In 2021, the FDA approved Semaglutide for weight loss for the general population. Doctors and patients are flocking to get this medication.

Children over the age of 12 are now eligible to be prescribed this drug as well. Many celebrities have confirmed their personal use of the drugs, including Oprah. Influencers across the social sphere are partnering with pharmaceutical companies to promote the drugs.

Today, we talk about these drugs, and combating weight stigma in and out the doctor’s office.

GUESTS:

Dr. Mara Gordon: Family Practice Physician from New Jersey

Devika Umashanker: System Medical Director for Obesity Medicine at Hartford Healthcare

Dr. Maria Asnis: Director of the Center for Weight Management at Stamford Health

Dr. Sherry Pagoto: Licensed Clinical Psychologist and Professor at University of Connecticut

Where We Live is available as a podcast on Apple Podcasts, Spotify, Google Podcasts, Amazon Music, TuneIn, Listen Notes, or wherever you get your podcasts. Subscribe and never miss an episode. Support the show: http://wnpr.org/donate See omnystudio.com/listener for privacy information.

More episodes from Where We Live